Stock BPH BPH ENERGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials BPH Energy Limited

Equities

BPH

AU000000BPH4

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 01:32:09 2024-04-30 am EDT 		5-day change 1st Jan Change
0.0205 AUD -2.38% Intraday chart for BPH Energy Limited +2.50% -56.38%
Feb. 28 BPH Energy Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Feb. 09 BPH Energy to Raise AU$2Million in Placement; Shares Fall 8% MT

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 0.9662 2.543 8.584 47.21 7.314 21.4
Enterprise Value (EV) 1 1.019 2.278 8.425 37.12 4.501 15.85
P/E ratio -0.49 x -0.59 x 7.09 x -25.4 x -6.79 x 23 x
Yield - - - - - -
Capitalization / Revenue 4.1 x 9.14 x 35.7 x 721 x 32.8 x 70.4 x
EV / Revenue 4.32 x 8.19 x 35.1 x 567 x 20.2 x 52.1 x
EV / EBITDA -2.14 x - - - - -
EV / FCF -4.67 x -1.17 x 4.47 x -31.7 x -20.3 x -8.76 x
FCF Yield -21.4% -85.6% 22.4% -3.16% -4.93% -11.4%
Price to Book 0.26 x 1.18 x 1.93 x 3.04 x 0.51 x 1.09 x
Nbr of stocks (in thousands) 96,619 254,328 373,237 664,919 664,948 930,235
Reference price 2 0.0100 0.0100 0.0230 0.0710 0.0110 0.0230
Announcement Date 9/30/18 9/30/19 9/30/20 10/31/21 9/9/22 8/16/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.2358 0.2782 0.2402 0.0655 0.2228 0.3041
EBITDA 1 -0.4772 - - - - -
EBIT 1 -0.4772 -3.366 2.301 -1.518 -0.69 -1.407
Operating Margin -202.34% -1,209.88% 957.98% -2,316.84% -309.61% -462.9%
Earnings before Tax (EBT) 1 -1.507 -3.013 1.121 -1.612 -1.079 0.8523
Net income 1 -1.506 -3.013 1.122 -1.612 -1.078 0.8534
Net margin -638.54% -1,082.86% 466.94% -2,460.63% -483.95% 280.68%
EPS 2 -0.0203 -0.0168 0.003243 -0.002800 -0.001621 0.000999
Free Cash Flow 1 -0.218 -1.95 1.887 -1.172 -0.2219 -1.809
FCF margin -92.44% -700.83% 785.25% -1,788.54% -99.56% -595.01%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - 168.17% - - -
Dividend per Share - - - - - -
Announcement Date 9/30/18 9/30/19 9/30/20 10/31/21 9/9/22 8/16/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 0.05 - - - - -
Net Cash position 1 - 0.27 0.16 10.1 2.81 5.55
Leverage (Debt/EBITDA) -0.1108 x - - - - -
Free Cash Flow 1 -0.22 -1.95 1.89 -1.17 -0.22 -1.81
ROE (net income / shareholders' equity) -37.9% -108% 35.7% -16.4% -7.27% 5.06%
ROA (Net income/ Total Assets) -5.07% -46.7% 30.1% -8.45% -2.72% -4.94%
Assets 1 29.7 6.453 3.732 19.08 39.67 -17.27
Book Value Per Share 2 0.0400 0.0100 0.0100 0.0200 0.0200 0.0200
Cash Flow per Share 2 0 0 0 0.0200 0 0.0100
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 9/30/18 9/30/19 9/30/20 10/31/21 9/9/22 8/16/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BPH ENERGY LIMITED Stock BPH Energy Limited
-56.38% 15.12M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.77% 42.86B
MODERNA, INC. Stock Moderna, Inc.
+12.24% 42.74B
LONZA GROUP AG Stock Lonza Group AG
+43.96% 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
-8.83% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.44% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.01% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.56% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.82% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.35% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BPH Stock
  4. Financials BPH Energy Limited